Clinical Trial Update: Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reports Phase 1 and Phase 2 results for the clearance of NRL972 in patients with hepatic cirrhosis and nonalcoholic steatohepatitis, as we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Cirrhosis
• Nonalcoholic Steatohepatitis

Drugs mentioned

• NRL972 (NRL972)

Snippet

Sponsor: Norgine | Conditions: Hepatic Cirrhosis, Nonalcoholic Steatohepatitis | Phase 1, Phase 2 | Status: COMPLETED